AMG 319 in HPV Positive and Negative HNSCC

NCT02540928 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

35

Enrollment

OTHER

Sponsor class

Stopped Safety Reasons

Conditions

Human Papillomavirus (HPV)
Positive or Negative Head and Neck Squamous Cell Carcinoma (HNSCC) of the Hypopharynx, Oropharynx, Oral Cavity, Supraglottis or Larynx

Interventions

DRUG: AMG 319 hydrate
DRUG: Placebo

Sponsor

Cancer Research UK